| P50 | author | Robert E Sinden | Q96030894 |
| P2093 | author name string | Robert E Sinden | |
| P2860 | cites work | Factors determining the true reservoir of infection of Plasmodium falciparum and Wuchereria bancrofti in a West African village | Q45277732 |
| | Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi | Q47953860 |
| | The distribution of Plasmodium falciparum in the peripheral blood and bone marrow of Gambian children | Q47991664 |
| | Low gametocyte thresholds of infection of Anopheles with Plasmodium falciparum; a significant factor in malaria epidemiology. | Q52613697 |
| | Wolbachia infections in natural Anopheles populations affect egg laying and negatively correlate with Plasmodium development | Q26314699 |
| | Ensuring transmission through dynamic host environments: host-pathogen interactions in Plasmodium sexual development | Q27007534 |
| | The time-course of protection of the RTS,S vaccine against malaria infections and clinical disease | Q27304630 |
| | Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development | Q27324132 |
| | Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond | Q27826351 |
| | Adhesion protein complexes of malaria gametocytes assemble following parasite transmission to the mosquito | Q27974518 |
| | Transmission-blocking strategies: the roadmap from laboratory bench to the community | Q28078982 |
| | The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 | Q28267425 |
| | A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses | Q28301446 |
| | Stage-Specific Changes in Plasmodium Metabolism Required for Differentiation and Adaptation to Different Host and Vector Environments | Q28468534 |
| | New developments in anti-malarial target candidate and product profiles | Q28468598 |
| | Synergistic and additive effects of epigallocatechin gallate and digitonin on Plasmodium sporozoite survival and motility | Q28472514 |
| | A research agenda for malaria eradication: drugs | Q28476806 |
| | The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites | Q28480979 |
| | Inferring developmental stage composition from gene expression in human malaria | Q28536897 |
| | Discovery of gene function by expression profiling of the malaria parasite life cycle | Q29547840 |
| | A novel multiple-stage antimalarial agent that inhibits protein synthesis | Q30044020 |
| | A high susceptibility to redox imbalance of the transmissible stages of Plasmodium falciparum revealed with a luciferase-based mature gametocyte assay | Q30044470 |
| | Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230. | Q30390705 |
| | Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. | Q30982324 |
| | Progression of Plasmodium berghei through Anopheles stephensi is density-dependent | Q33312856 |
| | Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. | Q33350210 |
| | A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli | Q33485233 |
| | A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies | Q33670142 |
| | Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes | Q33883479 |
| | Proteomic analysis of the Plasmodium male gamete reveals the key role for glycolysis in flagellar motility. | Q34116343 |
| | Plasmodium falciparum transmission stages accumulate in the human bone marrow | Q34245311 |
| | Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites | Q34298647 |
| | Sex-partitioning of the Plasmodium falciparum stage V gametocyte proteome provides insight into falciparum-specific cell biology | Q34303401 |
| | A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs | Q34597517 |
| | A quantitative high throughput assay for identifying gametocytocidal compounds | Q34605248 |
| | Changes in metabolic phenotypes of Plasmodium falciparum in vitro cultures during gametocyte development | Q34895018 |
| | Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations. | Q34922792 |
| | Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria | Q34968407 |
| | Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay | Q34995863 |
| | Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen. | Q35076804 |
| | N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity | Q35138720 |
| | A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum | Q35138735 |
| | Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres | Q35211679 |
| | Ookinete-interacting proteins on the microvillar surface are partitioned into detergent resistant membranes of Anopheles gambiae midguts | Q35526306 |
| | Pfs230: from malaria transmission-blocking vaccine candidate toward function | Q35548285 |
| | A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion | Q35618598 |
| | Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination. | Q35666885 |
| | Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum | Q35718341 |
| | Splenic retention of Plasmodium falciparum gametocytes to block the transmission of malaria | Q35746071 |
| | A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds | Q35836828 |
| | A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses | Q35887438 |
| | Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes | Q35898587 |
| | Proteomic analysis of Plasmodium in the mosquito: progress and pitfalls. | Q36159362 |
| | Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults | Q36165265 |
| | Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria elimination | Q36198846 |
| | Disrupting Mosquito Reproduction and Parasite Development for Malaria Control | Q36225334 |
| | Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts | Q36247867 |
| | Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology | Q36442817 |
| | Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models | Q36492529 |
| | A bioinformatics approach for integrated transcriptomic and proteomic comparative analyses of model and non-sequenced anopheline vectors of human malaria parasites. | Q36508101 |
| | Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine | Q36603519 |
| | Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics | Q36841992 |
| | Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection | Q36864852 |
| | Transmission-blocking interventions eliminate malaria from laboratory populations. | Q36906724 |
| | Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infection | Q36936348 |
| | Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs | Q36969808 |
| | Piperaquine Monotherapy of Drug-Susceptible Plasmodium falciparum Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia. | Q37003081 |
| | Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii | Q37160241 |
| | Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP. | Q37161928 |
| | Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates | Q37170062 |
| | Functional genomic analyses of Enterobacter, Anopheles and Plasmodium reciprocal interactions that impact vector competence. | Q37196207 |
| | Plasmodium infection and oxidative status in breeding great tits, Parus major | Q37394728 |
| | Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses | Q37402846 |
| | Environmental determinants of malaria transmission in African villages | Q37460862 |
| | Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study | Q37550665 |
| | Genetic relatedness analysis reveals the cotransmission of genetically related Plasmodium falciparum parasites in Thiès, Senegal | Q37602584 |
| | Assessing the infectious reservoir of falciparum malaria: past and future | Q38488692 |
| | The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity | Q38767298 |
| | A chemical susceptibility profile of the Plasmodium falciparum transmission stages by complementary cell-based gametocyte assays | Q38906634 |
| | Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions? | Q38917760 |
| | Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection | Q38949224 |
| | Sterile protection against human malaria by chemoattenuated PfSPZ vaccine | Q39267443 |
| | Dynamics of the Human Infectious Reservoir for Malaria Determined by Mosquito Feeding Assays and Ultrasensitive Malaria Diagnosis in Burkina Faso | Q39331193 |
| | Sexual Development of Malarial Parasites | Q40093039 |
| | The biology of Plasmodium in the mosquito | Q40096091 |
| | The cell biology of sexual development in Plasmodium | Q40107209 |
| | A key malaria metabolite modulates vector blood seeking, feeding, and susceptibility to infection. | Q40338119 |
| | Antibody-independent mechanisms regulate the establishment of chronic Plasmodium infection | Q40343704 |
| | Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions | Q41581139 |
| | The Measurement of Malaria Transmission | Q41844795 |
| | Epidemiological basis of malaria control | Q42118029 |
| | Theory of the eradication of malaria | Q42540722 |
| | Ejection of malaria sporozoites by feeding mosquitoes | Q43585414 |
| | A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs | Q44148145 |
| | Factors in malaria transmission by Anopheles albimanus in Jamaica. Part I. | Q44152051 |
| | Factors in malaria transmission by Anopheles albimanus in Jamaica. II. | Q44152099 |
| | The malarial infectivity of an African village population to mosquitoes (Anopheles gambiae); a random xenodiagnostic survey | Q44153727 |
| | Infectivity of Microscopic and Submicroscopic Malaria Parasite Infections in Areas of Low Malaria Endemicity | Q44155243 |
| | Cellular stress associated with the differentiation of Plasmodium berghei ookinetes | Q44163648 |
| | Assessing transmission blockade in Plasmodium spp. | Q44165859 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P921 | main subject | malaria transmission | Q56928847 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e1006336 | |
| P577 | publication date | 2017-07-01 | |
| | 2017-07-06 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Developing transmission-blocking strategies for malaria control | |
| P478 | volume | 13 | |